1. A novel type of implantable and programmable infusion pump for small laboratory animals;Abe;Journal of Pharmacological and Toxicological Methods,2009
2. The role of mechanism-based pharmacokinetic-pharmacodynamic (PK–PD) modelling in translational research of biologics;Agoram;Drug Discovery Today,2007
3. Affinity and intrinsic activity in the theory of competitive inhibition;Ariens;Archives Internationale de Pharmacodynamie et de Therapie,1954
4. Changes in plasma protein binding have little clinical relevance;Benet;Clinical Pharmacology & Therapeutics,2002
5. Benson, N., Snelder, N. Ploeger, B., Napier, C., Sale, H., Birdsall, N.J.M., Butt, R.P., & Van der Graaf, P.H. (in press). Estimation of binding rate constants using a simultaneous mixed-effects method; application to SS, RR and racemic reboxetine. British Journal of Pharmacology.